Fusion Antibodies plc

LSE:FAB.L

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

Location

United Kingdom

Market Cap

USD 9.81 M

Share Price

USD 0.08

Avg Daily Volume

547,776

Change (1 day)

-1.45%

Change (1 year)

126.81%

Change (YTD)

-3.70%

Fusion Antibodies plc Depreciation And Amortization for the year ending March 31, 2024: USD 277.59 K

Fusion Antibodies plc Depreciation And Amortization is USD 277.59 K for the year ending March 31, 2024, a -39.48% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.

Fusion Antibodies plc Depreciation And Amortization for the year ending March 31, 2023 was USD 458.64 K, a -53.50% change year over year.
Fusion Antibodies plc Depreciation And Amortization for the year ending March 31, 2022 was USD 986.34 K, a 0.27% change year over year.
Fusion Antibodies plc Depreciation And Amortization for the year ending March 31, 2021 was USD 983.70 K, a 27.45% change year over year.
Fusion Antibodies plc Depreciation And Amortization for the year ending March 31, 2020 was USD 771.81 K, a 37.32% change year over year.